1. Differential variations of sensitivities of TNP-modified lymphoma cells to lysis by cytotoxic lymphocytes and by antibodies;Bischoff;Immun. Lett.,1982
2. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunised in vivo and in vitro and non-specifically expanded by culture with interleukin 2;Cheever;J. Immun.,1981
3. The effect of inhibitors of macromolecular synthesis on neutrophil-mediated antibody-dependent cellular cytotoxicity: exacerbation by mitomycin C;Dale;Int. J. Immunopharmac.,1984
4. Evidence of a dynamic role of the target cell membrane during the early stage of the natural killer cell lethal hit;Deem;J. Immun.,1984
5. The systemic administration of purified interleukin 2 enhances the ability of sensitized lymphocytes to cure a disseminated syngeneic lymphoma;Donohue;J. Immun.,1984